Test Directory
| Test Code | ||||
| ISAVU | ||||
| Test Name | ||||
| Isavuconazole | ||||
| CPT Codes | ||||
| 80299 | ||||
| Expected Turnaround Time | ||||
| Varies | ||||
| Clinical Utility | ||||
| Isavuconazole is for the treatment of life threatening fungal infections, specifically invasive aspergillosis and invasive mucormycosis. There is a significant need for alternative antifungal therapies that address some of the limitations of voriconazole, such as reduced potential for nephrotoxicity for the intravenous formulation, in addition to other dose-related toxicities. Given the difficulty in diagnosis and similarity with which infections may present, having an antifungal that is effective for both indications would be particularly useful to physicians treating immunocompromised patients. | ||||
| Specimen and Container Info | ||||
|
Specimen Type: Serum Collection Container: Red Top, Plain Desired Specimen Volume: 1 mL |
||||
| Collection Instructions | ||||
|
||||
| Processing and Submission Instructions | ||||
|
||||
| Transport Instructions | ||||
|
Transport to the laboratory frozen. |
||||
| Stability Requirements | ||||
|
||||
| Causes for Rejection | ||||
|
||||
| Methodology | ||||
| Reversed-Phase Uplc-Ms/Ms | ||||
| Reference Intervals | ||||
|
See patient report. |
||||
| Alternate Names | ||||
|
Cresemba |
||||
| Reference Lab | ||||
| Mayo Clinic Laboratories | ||||
| Testing Schedule | ||||
| Varies | ||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.